AMA
Hussain T, Gupta K, Tiwari A, Mishra P. Polypharmacy’s paradox: accelerated decline in a rare case of Lafora body disease. Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii. 2026;35(2):141-145. doi:10.5114/ppn.2026.161380.
APA
Hussain, T., Gupta, K., Tiwari, A., & Mishra, P. (2026). Polypharmacy’s paradox: accelerated decline in a rare case of Lafora body disease. Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii, 35(2), 141-145. https://doi.org/10.5114/ppn.2026.161380
Chicago
Hussain, Tasneem, Krishna Gupta, Ashutosh Tiwari, and Pooja S. Mishra. 2026. "Polypharmacy’s paradox: accelerated decline in a rare case of Lafora body disease". Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii 35 (2): 141-145. doi:10.5114/ppn.2026.161380.
Harvard
Hussain, T., Gupta, K., Tiwari, A., and Mishra, P. (2026). Polypharmacy’s paradox: accelerated decline in a rare case of Lafora body disease. Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii, 35(2), pp.141-145. https://doi.org/10.5114/ppn.2026.161380
MLA
Hussain, Tasneem et al. "Polypharmacy’s paradox: accelerated decline in a rare case of Lafora body disease." Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii, vol. 35, no. 2, 2026, pp. 141-145. doi:10.5114/ppn.2026.161380.
Vancouver
Hussain T, Gupta K, Tiwari A, Mishra P. Polypharmacy’s paradox: accelerated decline in a rare case of Lafora body disease. Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii. 2026;35(2):141-145. doi:10.5114/ppn.2026.161380.